BEATRIZ
SUÁREZ ÁLVAREZ
Universidad Complutense de Madrid
Madrid, EspañaUniversidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2024
-
BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury
Biomedicine and Pharmacotherapy, Vol. 174
2017
-
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
Oncotarget, Vol. 8, Núm. 19, pp. 31959-31976